DE69022121D1 - Verfahren zur Herstellung eines Metastaseninhibitorenfaktors. - Google Patents

Verfahren zur Herstellung eines Metastaseninhibitorenfaktors.

Info

Publication number
DE69022121D1
DE69022121D1 DE69022121T DE69022121T DE69022121D1 DE 69022121 D1 DE69022121 D1 DE 69022121D1 DE 69022121 T DE69022121 T DE 69022121T DE 69022121 T DE69022121 T DE 69022121T DE 69022121 D1 DE69022121 D1 DE 69022121D1
Authority
DE
Germany
Prior art keywords
mif
metastasis
preparation
hematopoietic cells
metastasis inhibitor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69022121T
Other languages
English (en)
Other versions
DE69022121T2 (de
Inventor
Masashi Kurimoto
Ryuichi Motoda
Kanso Iwaki
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hayashibara Seibutsu Kagaku Kenkyujo KK
Original Assignee
Hayashibara Seibutsu Kagaku Kenkyujo KK
Hayashibara Biochemical Laboratories Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hayashibara Seibutsu Kagaku Kenkyujo KK, Hayashibara Biochemical Laboratories Co Ltd filed Critical Hayashibara Seibutsu Kagaku Kenkyujo KK
Application granted granted Critical
Publication of DE69022121D1 publication Critical patent/DE69022121D1/de
Publication of DE69022121T2 publication Critical patent/DE69022121T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • C07K14/4703—Inhibitors; Suppressors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Biophysics (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Cell Biology (AREA)
  • Plant Pathology (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE69022121T 1989-05-22 1990-05-21 Verfahren zur Herstellung eines Metastaseninhibitorenfaktors. Expired - Fee Related DE69022121T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP1128362A JP2926409B2 (ja) 1989-05-22 1989-05-22 癌転移抑制因子の製造方法

Publications (2)

Publication Number Publication Date
DE69022121D1 true DE69022121D1 (de) 1995-10-12
DE69022121T2 DE69022121T2 (de) 1996-04-04

Family

ID=14982946

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69022121T Expired - Fee Related DE69022121T2 (de) 1989-05-22 1990-05-21 Verfahren zur Herstellung eines Metastaseninhibitorenfaktors.

Country Status (11)

Country Link
US (1) US5126148A (de)
EP (1) EP0401997B1 (de)
JP (1) JP2926409B2 (de)
KR (1) KR0157227B1 (de)
AT (1) ATE127527T1 (de)
CA (1) CA2017279A1 (de)
DE (1) DE69022121T2 (de)
DK (1) DK0401997T3 (de)
ES (1) ES2080114T3 (de)
GR (1) GR3018004T3 (de)
RU (1) RU2070046C1 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3439490B2 (ja) * 1992-09-28 2003-08-25 株式会社林原生物化学研究所 蛋白質とその蛋白質をコードするｄｎａ並びにその蛋白質の製造方法
JPH1080270A (ja) * 1996-07-19 1998-03-31 Hayashibara Biochem Lab Inc ポリペプチドをプロセッシングする酵素

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4785077A (en) * 1986-05-05 1988-11-15 Scripps Clinic And Research Foundation Substantially pure cytotoxicity triggering factor

Also Published As

Publication number Publication date
EP0401997B1 (de) 1995-09-06
GR3018004T3 (en) 1996-02-29
KR900018379A (ko) 1990-12-21
DK0401997T3 (da) 1995-10-16
US5126148A (en) 1992-06-30
ATE127527T1 (de) 1995-09-15
EP0401997A1 (de) 1990-12-12
JPH02308799A (ja) 1990-12-21
KR0157227B1 (ko) 1998-10-15
JP2926409B2 (ja) 1999-07-28
ES2080114T3 (es) 1996-02-01
DE69022121T2 (de) 1996-04-04
RU2070046C1 (ru) 1996-12-10
CA2017279A1 (en) 1990-11-22

Similar Documents

Publication Publication Date Title
DE60025015D1 (de) Verfahren zur herstellung von rekombinanten proteinen mittels inhibitoren von apoptose
LV11783A (lv) Savienojumi un metodes megakariocitu augsanas un diferencesanas stimulesanai
ATE174058T1 (de) Herstellung von proteinen mittels homologer rekombination
KR950700989A (ko) 사람 수지상 세포의 시험관내 생성방법 및 이의 용도(In vitro generation of human dendritic cells and uses thereof)
DE69333433D1 (de) Verfahren zur in vitro kultivierung dendritischer vorläuferzellen und deren verwendung zur immunogen herstellung
EP0453453A4 (en) Leukaemia inhibitory factor from livestock species and use thereof to enhance implantation and development of embryonic cells
BR8301918A (pt) Proteina,sequencia de dna,veiculo de expressao replicavel,microorganismo ou cultura celular,plasmideo,composicao,cultura de celulas,utilizacao de tal proteina,processo de expressao,processo para producao de um veiculo de expressao e processo para preparacao de uma proteina uroquinase
ATE79720T1 (de) Verfahren zur konservierung von transplantierbaren, in vitro kultivierten epithelgeweben.
DE69533941D1 (de) Verfahren zur herstellung eines arzneimittels zur behandlung des sekundärimmunmangels
ATE2442T1 (de) Verfahren zur herstellung von interferon und dabei verwendete kulturmediumzusammensetzung.
MY131053A (en) 2-saccharinylmethyl aryl carboxylates useful as proteolytic enzyme inhibitors and compositions and method of use thereof
ATE15693T1 (de) Zellkultur-verfahren.
ATE5726T1 (de) Verfahren zur herstellung von antibiotikum c15003 p3.
MY131384A (en) Novel 2-saccharinylmethyl aryl carboxylates useful as proteolytic enzyme inhibitors and compositions and method of use thereof
DE69022121D1 (de) Verfahren zur Herstellung eines Metastaseninhibitorenfaktors.
ATE21119T1 (de) Verfahren zur herstellung von 3-oxo-delta-1,4steroiden.
DE3786705D1 (de) Verwendung eines ornithin-decarboxylate-inhibitors zur herstellung eines praeparats fuer die behandlung, zusammen mit lak-zellen und interleukin-2, von tumoren.
ATE113593T1 (de) Verfahren zur herstellung von polyalkyl-2-alkoxy- 7-hydroxychromanderivate.
ATE47427T1 (de) Verfahren zur herstellung von arphamenin mit hoher ausbeute.
ATE16999T1 (de) Verfahren zur herstellung von carbaminsaeureestern.
AT339848B (de) Fermenter zur zuchtung von mikroorganismen, insbesondere von backhefe
ATE49401T1 (de) Verfahren zur herstellung von alkylarylethern.
JPS57186491A (en) Cultivation of fibroblast using fibronectin
PT89357A (pt) Tumores reconstituidos, processo de obtencao e equipamento ("kit") de laboratorio para a sua execucao
JPS5210487A (en) Production of gluconic acid or salts thereof by fermentation

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee